Morpholino

MO1-alms1

ID
ZDB-MRPHLNO-160310-5
Name
MO1-alms1
Previous Names
  • e4i4 (1)
Target
Sequence
5' - TTAAGTGCTGAACTTACCGGGATTC - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-alms1
Phenotype
Phenotype resulting from MO1-alms1
Phenotype Fish Figures
pancreatic B cell decreased amount, abnormal jh2Tg + MO1-alms1 Fig. 1. with image from Hostelley et al., 2021
Fig. 1 from Lodh et al., 2016
pancreatic B cell mCherry expression decreased amount, abnormal jh2Tg + MO1-alms1 Fig. 1 from Lodh et al., 2016
pancreatic B cell decreased area, abnormal jh2Tg + MO1-alms1 Fig. 1 from Lodh et al., 2016
pancreatic B cell decreased mass, abnormal jh2Tg + MO1-alms1 Fig. 1 from Lodh et al., 2016
whole organism vtg7 expression decreased amount, abnormal TU + MO1-alms1 Fig. 7 from Hostelley et al., 2016
whole organism ctrb.1 expression decreased amount, abnormal TU + MO1-alms1 Fig. S3 from Hostelley et al., 2016
whole organism gvin1l expression decreased amount, abnormal TU + MO1-alms1 Fig. 7 from Hostelley et al., 2016
whole organism cela1.6 expression decreased amount, abnormal TU + MO1-alms1 Fig. 7Fig. S3 from Hostelley et al., 2016
whole organism c3a.2 expression decreased amount, abnormal TU + MO1-alms1 Fig. 7 from Hostelley et al., 2016
whole organism snord31.1 expression decreased amount, abnormal TU + MO1-alms1 Fig. 7 from Hostelley et al., 2016
whole organism snord31.2 expression decreased amount, abnormal TU + MO1-alms1 Fig. 7 from Hostelley et al., 2016
whole organism ctrl expression decreased amount, abnormal TU + MO1-alms1 Fig. S3 from Hostelley et al., 2016
whole organism prss1 expression decreased amount, abnormal TU + MO1-alms1 Fig. S3 from Hostelley et al., 2016
whole organism prss59.1 expression decreased amount, abnormal TU + MO1-alms1 Fig. 7Fig. S3 from Hostelley et al., 2016
whole organism smc1b expression increased amount, abnormal TU + MO1-alms1 Fig. 7 from Hostelley et al., 2016
Phenotype of all Fish created by or utilizing MO1-alms1
Phenotype Fish Conditions Figures
whole organism c3a.2 expression decreased amount, abnormal TU + MO1-alms1 standard conditions Fig. 7 from Hostelley et al., 2016
whole organism ctrl expression decreased amount, abnormal TU + MO1-alms1 standard conditions Fig. S3 from Hostelley et al., 2016
whole organism gvin1l expression decreased amount, abnormal TU + MO1-alms1 standard conditions Fig. 7 from Hostelley et al., 2016
whole organism snord31.1 expression decreased amount, abnormal TU + MO1-alms1 standard conditions Fig. 7 from Hostelley et al., 2016
whole organism snord31.2 expression decreased amount, abnormal TU + MO1-alms1 standard conditions Fig. 7 from Hostelley et al., 2016
whole organism ctrb.1 expression decreased amount, abnormal TU + MO1-alms1 standard conditions Fig. S3 from Hostelley et al., 2016
whole organism prss59.1 expression decreased amount, abnormal TU + MO1-alms1 standard conditions Fig. 7Fig. S3 from Hostelley et al., 2016
whole organism vtg7 expression decreased amount, abnormal TU + MO1-alms1 standard conditions Fig. 7 from Hostelley et al., 2016
whole organism cela1.6 expression decreased amount, abnormal TU + MO1-alms1 standard conditions Fig. 7Fig. S3 from Hostelley et al., 2016
glucose homeostasis disrupted, abnormal TU + MO1-alms1 chemical treatment: D-glucopyranose Fig. 7 from Lodh et al., 2016
whole organism prss1 expression decreased amount, abnormal TU + MO1-alms1 standard conditions Fig. S3 from Hostelley et al., 2016
whole organism smc1b expression increased amount, abnormal TU + MO1-alms1 standard conditions Fig. 7 from Hostelley et al., 2016
pancreatic B cell decreased amount, abnormal WT + MO1-alms1 standard conditions Fig. 1. with image from Hostelley et al., 2021
pancreatic B cell mCherry expression decreased amount, abnormal jh2Tg + MO1-alms1 standard conditions Fig. 1 from Lodh et al., 2016
apoptotic process increased occurrence, abnormal jh2Tg + MO1-alms1 chemical treatment: D-glucopyranose Fig. 5 from Lodh et al., 2016
pancreatic B cell decreased mass, abnormal jh2Tg + MO1-alms1 standard conditions Fig. 1 from Lodh et al., 2016
pancreatic B cell decreased amount, abnormal jh2Tg + MO1-alms1 standard conditions Fig. 1 from Lodh et al., 2016
pancreatic B cell decreased area, abnormal jh2Tg + MO1-alms1 standard conditions Fig. 1 from Lodh et al., 2016
pancreatic B cell decreased amount, abnormal jh2Tg + MO1-alms1 chemical treatment: D-glucopyranose Fig. 3 from Lodh et al., 2016
pancreatic B cell apoptotic, abnormal jh2Tg + MO1-alms1 chemical treatment: D-glucopyranose Fig. 5 from Lodh et al., 2016
pancreas regeneration disrupted, abnormal jh4Tg + MO1-alms1 chemical treatment: metronidazole Fig. 6 from Lodh et al., 2016
Citations